← Leaderboards
Chemtai Mungo
Univ Of North Carolina Chapel Hill
$1,427,241
Attributed
$1,427,241
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $901.9K · FY2023–25$1M$750K$500K$250K$0
'23
'24
'25
Funding mix
By agency
NIH$1,427,241 · 2
By mechanism
R34$738,783 · 1
R37$688,458 · 1
Top collaborators
No co-investigators on record.
Most similar at Univ Of North Carolina Chapel Hill
Same institution · by research overlap
- David N Hayes$17,915,459
- Natalia Issaeva$2,582,417
- Samuel Lai$12,082,303
- Keely Ann Muscatell$2,953,265
- Jonathan J Juliano$19,413,943
Others in their field
Other Rising Stars on “Malignant Neoplasm Of Cervix Uteri”
- Carolina Porras · Fundacion Inciensa$11,134,023
- Katharine A. Rendle · University Of Pennsylvania$2,942,423
- Anne Rietz · Kovina Therapeutics Inc.$2,330,674
- Manijeh Goldberg · Privo Technologies, Llc$2,049,944
- Shaun Barnabas · Stellenbosch University$2,014,842
- Amanda F. Petrik · Kaiser Foundation Research Institute$2,011,364
Research focus
Malignant Neoplasm Of Cervix UteriLow And Middle-Income CountriesFaceIncidenceInvestigationLesionCost EffectiveEnrollmentFutureHuman Papilloma Virus InfectionAdjuvant TherapyInnovationAdherenceKenyaAdjuvantCervical Intraepithelial NeoplasiaAblationClinicAccountingCollaborationsHuman PapillomavirusCervicalCervical Cancer PreventionParticipant
Grant awards (8)
Expanded Safety and Preliminary Efficacy of Adjuvant 5-Fluorouracil Following Thermal Ablation to Improve HPV Treatment Outcomes in Women with HIV in Africa$605,863
R37 · FY2025 · CA · contact PI
Feasibility of artesunate to improve HPV and cervical precancer treatment outcomes among HIV positive women in LMICs$145,386
R34 · FY2025 · CA · contact PI
Expanded Safety and Preliminary Efficacy of Adjuvant 5-Fluorouracil Following Thermal Ablation to Improve HPV Treatment Outcomes in Women with HIV in Africa$48,531
R37 · FY2025 · CA · contact PI
Feasibility of artesunate to improve HPV and cervical precancer treatment outcomes among HIV positive women in LMICs$41,081
R34 · FY2025 · CA · contact PI
Expanded Safety and Preliminary Efficacy of Adjuvant 5-Fluorouracil Following Thermal Ablation to Improve HPV Treatment Outcomes in Women with HIV in Africa$34,064
R37 · FY2025 · CA · contact PI
Feasibility of artesunate to improve HPV and cervical precancer treatment outcomes among HIV positive women in LMICs$26,957
R34 · FY2025 · CA · contact PI
Feasibility of artesunate to improve HPV and cervical precancer treatment outcomes among HIV positive women in LMICs$278,390
R34 · FY2024 · CA · contact PI
Feasibility of artesunate to improve HPV and cervical precancer treatment outcomes among HIV positive women in LMICs$246,969
R34 · FY2023 · CA · contact PI